EUVIMEDEUVIMED entdecken
Crossref

Increased Nasal Blimp1 + Treg Cells After Sublingual Immunotherapy Reflect the Efficacy of Treatment in Allergic Rhinitis

Yue Pan, Xinxin Zhang, Huanting Geng, Yan Yu, Jianyong Liu, Menglin Li, Huijun Yang, Yifang Yuan, Yao Xu, Yujia Wu, Geping Wu iD, Xingkai Ma und 1 weitere

Advances in Therapy · 2024

DOI: 10.1007/s12325-024-02819-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Therapy, 2024. Verfasst von Yue Pan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Zhangjiagang Hospital Affiliated to Soochow University, Suzhou, 215600, China. Hauptthemen laut MEDLINE: Sublingual Immunotherapy, Rhinitis, Allergic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Allergen-specific immunotherapy (AIT) plays a pivotal role in altering the immune status and tissue responses in allergic rhinitis (AR). This study focuses on the impact of sublingual immunotherapy (SLIT) involving dust mite drops, exploring the modulation of regulatory T cells (Treg) and their specific marker, BLIMP1, in the nasal mucosa. METHODS: Immune cells were isolated from nasal lavage fluid of patients with AR undergoing SLIT (n = 94). Treg cells were analyzed for BLIMP1 expression, and chemokine levels associated with Treg recruitment were assessed using Luminex assay. Patients were categorized on the basis of SLIT efficacy and followed for changes after discontinuation. RESULTS: SLIT induced a significant increase in nasal Treg cells (7.09 ± 2.59% vs. 0.75 ± 0.27%, P < 0.0001). BLIMP1 expression in Treg cells notably increased after SLIT (0.36 ± 0.22% to 16.86 ± 5.74%, P < 0.0001). Ineffective SLIT cases exhibited lower levels of nasal Treg and Blimp1 + Treg cells (both P < 0.0001). Receiver operating characteristic (ROC) analysis confirmed their potential as efficacy predictors (AUC = 0.908 and 0.968, respectively). SLIT discontinuation led to a significant reduction in Treg and Blimp1 + Treg cells (P < 0.001), emphasizing their maintenance during treatment. Pro-inflammatory cytokines decreased (P < 0.001), while CCL2 associated with Treg recruitment increased (P = 0.0015). CONCLUSION: Elevated nasal Blimp1 + Treg cells serve as a predictive biomarker for SLIT responsiveness in pediatric AR. Their influence on immunotherapy effectiveness contributes to a nuanced understanding of SLIT mechanisms, allowing for disease stratification and personalized treatment plans. This study offers scientific support for predicting SLIT efficacy, enhancing the prospects of improved treatment outcomes in AR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sublingual ImmunotherapyRhinitis, AllergicHumansChildT-Lymphocytes, RegulatoryTreatment OutcomeCytokinesAllergens

Stichwörter der Autor:innen

Allergic rhinitisBlimp1Sublingual immunotherapyToleranceTreg

Substanzen

CytokinesAllergens

Autor:innen und Institutionen

  • Department of Otolaryngology, Zhangjiagang Hospital Affiliated to Soochow University, Suzhou, 215600, China.
  • Department of Otolaryngology, Zhangjiagang Hospital Affiliated to Soochow University, Suzhou, 215600, China. wgp0325@suda.edu.cn.
  • Office of Science Education, Zhangjiagang Hospital Affiliated to Soochow University, 68 West Jiyang Road, Suzhou, 215000, China. wgp0325@suda.edu.cn.
  • Information Center, Zhangjiagang Hospital Affiliated to Soochow University, Suzhou, 215000, China.
  • Department of Otorhinolaryngology and Clinical Allergy Center, The First Affiliated Hospital, Nanjing Medical University, Nanjing, 210029, China. chenglei@jsph.org.cn.

ORCID-Profile: Geping Wu

Zitieren

APA

Pan, Y., Zhang, X., Geng, H., Yu, Y., Liu, J., Li, M., Yang, H., Yuan, Y., Xu, Y., Wu, Y., Wu, G., Ma, X., & Cheng, L. (2024). Increased Nasal Blimp1 + Treg Cells After Sublingual Immunotherapy Reflect the Efficacy of Treatment in Allergic Rhinitis. Advances in Therapy. https://doi.org/10.1007/s12325-024-02819-8

Vancouver

Pan Y, Zhang X, Geng H, Yu Y, Liu J, Li M, et al. Increased Nasal Blimp1 + Treg Cells After Sublingual Immunotherapy Reflect the Efficacy of Treatment in Allergic Rhinitis. Advances in Therapy. 2024. doi:10.1007/s12325-024-02819-8

BibTeX
@article{Pan2024,
  author = {Pan, Yue and Zhang, Xinxin and Geng, Huanting and Yu, Yan and Liu, Jianyong and Li, Menglin and Yang, Huijun and Yuan, Yifang and Xu, Yao and Wu, Yujia and Wu, Geping and Ma, Xingkai and Cheng, Lei},
  title = {Increased Nasal Blimp1 + Treg Cells After Sublingual Immunotherapy Reflect the Efficacy of Treatment in Allergic Rhinitis},
  journal = {Advances in Therapy},
  year = {2024},
  doi = {10.1007/s12325-024-02819-8}
}
Kostenlos starten →